A Phase I Study of a Novel Fully Human BCMA-Targeting CAR (CT103A) in Patients with Relapsed/Refractory Multiple Myeloma | Request PDF

Source : https://www.researchgate.net/publication/348673906_A_Phase_I_Study_of_a_Novel_Fully_Human_BCMA-Targeting_CAR_CT103A_in_Patients_with_RelapsedRefractory_Multiple_Myeloma

Request PDF | A Phase I Study of a Novel Fully Human BCMA-Targeting CAR (CT103A) in Patients with Relapsed/Refractory Multiple Myeloma | B cell maturation antigen- (BCMA) specific chimeric antigen receptor (CAR) T-cell therapies have shown efficacy in relapsed, refractory multiple...